Abstract
Fab I, enoyl acyl carrier protein reductase (ENR), is an enzyme used in fatty acid synthesis. It is a single chain polypeptide in plants, bacteria, and mycobacteria, but is part of a complex polypeptide in animals and fungi. Certain other enzymes in fatty acid synthesis in apicomplexan parasites appear to have multiple forms, homologous to either a plastid, plant-like single chain enzyme or more like the animal complex polypeptide chain. We identified a plant-like Fab I in Plasmodium falciparum and modelled the structure on the Brassica napus and Escherichia coli structures, alone and complexed to triclosan (5-chloro-2-[2,4 dichlorophenoxy] phenol]), which confirmed all the requisite features of an ENR and its interactions with triclosan. Like the remarkable effect of triclosan on a wide variety of bacteria, this compound markedly inhibits growth and survival of the apicomplexan parasites P. falciparum and Toxoplasma gondii at low (i.e. IC50 congruent with150-2000 and 62 ng/ml, respectively) concentrations. Discovery and characterisation of an apicomplexan Fab I and discovery of triclosan as lead compound provide means to rationally design novel inhibitory compounds.
Original language | English |
---|---|
Pages (from-to) | 109-113 |
Number of pages | 5 |
Journal | International Journal for Parasitology |
Volume | 31 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2001 |
Keywords
- amino acid sequence
- animals
- antimalarials
- enoyl-(acyl-carrier-protein) reductase (NADH)
- enzyme inhibitors
- humans
- models, molecular
- molecular sequence data
- oxidoreductases
- plasmodium falciparum
- sequence alignment
- toxoplasma
- triclosan